Page last updated: 2024-09-04

cariporide and Coronary Disease

cariporide has been researched along with Coronary Disease in 6 studies

Research

Studies (6)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	2 (33.33)	18.2507
2000's	4 (66.67)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chaitman, BR; Chi, E; Danchin, N; Erhardt, L; Gallo, R; Gavard, JA; Jessel, A; Sakai, S; Stocke, K; Théroux, P	1
Bartels, C; Bolli, R; Boyce, S; Buckberg, GD; Chaitman, B; Haverich, A; Knight, J; Menasché, P; Mentzer, RM; Myers, ML; Nicolau, J; Simoons, M; Thulin, L; Weisel, RD	1
Arnold, JM; Chakrabarti, S; Feng, Q; Haist, JV; Humphreys, RA; Karmazyn, M	1
Ferguson, JJ	1
Karmazyn, M	1
Briand, V; Cremer, G; Duval, N; Favennec, E; Grosset, A; Hoornaert, C; Janiak, P; Latham, C; Lorrain, J; O'Connor, SE	1

Reviews

1 review(s) available for cariporide and Coronary Disease

Article	Year
Pharmacology and clinical assessment of cariporide for the treatment coronary artery diseases. Expert opinion on investigational drugs, 2000, Volume: 9, Issue:5 Topics: Animals; Anti-Arrhythmia Agents; Coronary Disease; Guanidines; Heart Failure; Humans; Sodium-Hydrogen Exchangers; Sulfones	2000

Trials

1 trial(s) available for cariporide and Coronary Disease

Article	Year
Sodium-hydrogen exchange inhibition by cariporide to reduce the risk of ischemic cardiac events in patients undergoing coronary artery bypass grafting: results of the EXPEDITION study. The Annals of thoracic surgery, 2008, Volume: 85, Issue:4 Topics: Adult; Aged; Confidence Intervals; Coronary Angiography; Coronary Artery Bypass; Coronary Disease; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Follow-Up Studies; Guanidines; Hospital Mortality; Humans; Infusions, Intravenous; Male; Middle Aged; Myocardial Ischemia; Postoperative Complications; Preoperative Care; Probability; Reference Values; Risk Assessment; Severity of Illness Index; Sodium-Hydrogen Exchangers; Sulfones; Survival Analysis; Treatment Outcome	2008

Article

Year

Sodium-hydrogen exchange inhibition by cariporide to reduce the risk of ischemic cardiac events in patients undergoing coronary artery bypass grafting: results of the EXPEDITION study.

The Annals of thoracic surgery, 2008, Volume: 85, Issue:4

Topics: Adult; Aged; Confidence Intervals; Coronary Angiography; Coronary Artery Bypass; Coronary Disease; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Follow-Up Studies; Guanidines; Hospital Mortality; Humans; Infusions, Intravenous; Male; Middle Aged; Myocardial Ischemia; Postoperative Complications; Preoperative Care; Probability; Reference Values; Risk Assessment; Severity of Illness Index; Sodium-Hydrogen Exchangers; Sulfones; Survival Analysis; Treatment Outcome

2008

Other Studies

4 other study(ies) available for cariporide and Coronary Disease

Article	Year
Prognostic significance of elevated creatine kinase MB after coronary bypass surgery and after an acute coronary syndrome: results from the GUARDIAN trial. The Journal of thoracic and cardiovascular surgery, 2003, Volume: 126, Issue:3 Topics: Acute Disease; Aged; Coronary Artery Bypass; Coronary Disease; Creatine Kinase; Creatine Kinase, MB Form; Female; Guanidines; Humans; Isoenzymes; Male; Middle Aged; Myocardial Ischemia; Postoperative Period; Prognosis; Sodium-Hydrogen Exchangers; Sulfones; Survival Rate; Syndrome	2003
Orally administered NHE1 inhibitor cariporide reduces acute responses to coronary occlusion and reperfusion. The American journal of physiology, 1999, Volume: 276, Issue:2 Topics: Administration, Oral; Animals; Anti-Arrhythmia Agents; Apoptosis; Arrhythmias, Cardiac; bcl-2-Associated X Protein; Coronary Disease; Guanidines; Incidence; Male; Myocardial Reperfusion Injury; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcl-2; Rats; Rats, Sprague-Dawley; RNA, Messenger; Sodium-Hydrogen Exchangers; Sulfones	1999
Meeting highlights. Highlights of the 48th scientific sessions of the American College of Cardiology. Circulation, 1999, Aug-10, Volume: 100, Issue:6 Topics: Abciximab; Alanine; Angioplasty, Balloon, Coronary; Angiotensin-Converting Enzyme Inhibitors; Antibodies, Monoclonal; Aspirin; Benzamidines; Biphenyl Compounds; Cardiology; Cardiovascular Agents; Clinical Trials as Topic; Clopidogrel; Combined Modality Therapy; Coronary Disease; Dalteparin; Defibrillators, Implantable; Double-Blind Method; Enalapril; Endothelial Growth Factors; Fatty Acids, Omega-3; Guanidines; Heart Failure; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Immunoglobulin Fab Fragments; Laser Therapy; Lymphokines; Metoprolol; Multicenter Studies as Topic; Myocardial Revascularization; Platelet Aggregation Inhibitors; Pyrrolidines; Randomized Controlled Trials as Topic; Simvastatin; Sodium-Hydrogen Exchangers; Stents; Sulfones; Thrombolytic Therapy; Ticlopidine; Tissue Plasminogen Activator; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors; Vitamin E	1999
Pharmacological profile of SL 59.1227, a novel inhibitor of the sodium/hydrogen exchanger. British journal of pharmacology, 2000, Volume: 131, Issue:6 Topics: Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Benzamides; Blood Pressure; Coronary Disease; Guanidines; Heart Rate; Heart Ventricles; Hydrogen-Ion Concentration; Imidazoles; Male; Myocardial Ischemia; Myocardial Reperfusion Injury; Piperidines; Rabbits; Rats; Rats, Sprague-Dawley; Sodium-Hydrogen Exchangers; Sulfones	2000